目的对比动力髋螺钉(DHS)和股骨近端防旋髄内钉(PFNA)治疗Tronzo-Evans Ⅰ型、Ⅱ型股骨转子间骨折的临床疗效。方法选取60例Tronzo -Evans Ⅰ型、Ⅱ型股骨转子间骨折患者,其中接受DHS内固定治疗的28例为DHS组,同期接受PFNA内固定治疗且一般资料与DHS组患者均衡可比的32例为PFNA 组。比较两组患者的治疗效果和医疗费用。结果PFNA组手术时间、术中出血量、术后引流量少于DHS组(均P<0.05)。两组骨折愈合时间及术后3个月、6个月、12个月的Harris评分比较,差异均无统计学意义(均P>0.05)。两组并发症发生率比较(10.71% vs. 9.38%),差异无统计学意义(P>0.05)。PFNA组治疗总费用为(17 000±500)元,高于DHS组的(11 000±800)元(P<0.05)。结论对于Tronzo-Evans Ⅰ型、Ⅱ型股骨转子间骨折,如果患者手术耐受能力差,考虑到手术时间、术中出血量、术后引流量等问题,建议给予PFNA治疗。如果患者身体状况许可,因为两种术式远期效果一致,而DHS医疗费用相对较低,对于基层医院和经济困难的患者可作为一种很好的选择。
ObjectiveTo compare the clinical efficacy of dynamic hip screw (DHS) versus proximal femoral nail antirotation (PFNA) in the treatment of Tronzo-Evans typeⅠ and type Ⅱ femoral intertrochanteric fractures. MethodsSixty femoral intertrochanteric fractures patients in Tronzo-Evans typeⅠand typeⅡ were selected, of which 28 cases received DHS internal fixation as DHS group, whereas 32 cases, whose general data were comparable to the DHS group, received PFNA internal fixation during the same period as PFNA group. The therapeutic effect and hospitalization costs were compared between the two groups. ResultsThe operation time, intraoperative blood loss, and postoperative drainage volume of the PFNA group were less than those of the DSH group (all P<0.05). There were no significant differences in fracture healing time, Harris scores 3, 6, and 12 months after operation (all P>0.05). There was no significant difference in the incidence of complications between the two groups (10.71% vs. 9.38%, P>0.05). The total treatment costs of the PFNA group were (17,000±500) yuan, which were higher than those of the DHS group with (11,000±800) yuan (P<0.05). ConclusionFor femoral intertrochanteric fractures in Tronzo-Evans typeⅠand type Ⅱ, if the patient has poor surgical tolerance, considering the operation time, intraoperative blood loss, and postoperative drainage and other issues, PFNA is recommended. If the patient has a good physical condition, because of the same long-term effects of the two methods and the relatively low medical costs of DHS, it can be a good choice for primary hospitals and patients with economic difficulties.